ArticleJournal of interventional cardiology2022

Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients.

Yongjun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.